MedTech Spectrum

Article Name Medtech

Tevogen Bio engages BARDA TechWatch on ExacTcell™ as a scalable medical countermeasure

The discussion highlights ExacTcell™ Technology’s potential in advancing scalable solutions for medical preparedness.

10th February, 2025

Pharming Technologies completes acquisition of Abliva AB, extends acceptance period

The recommended cash offer to Abliva shareholders is now unconditional, with an extended acceptance period.

10th February, 2025

Healthmap Solutions acquires Carium to boost digital engagement in Population Health

Enhancing patient-centric care with advanced digital tools and analytics.

07th February, 2025

Senseonics Submits Eversense 365 for CE Mark Approval

The world’s longest-lasting continuous glucose monitor moves closer to European market approval.

07th February, 2025

Wyss Center Partners with BrainScape Medical to License Groundbreaking Epios® Technology

The collaboration aims to drive long-term brain monitoring and neurostimulation innovations into clinical applications.

06th February, 2025

BD Announces Intent to Separate Biosciences and Diagnostic Solutions Business to Enhance Focus, Drive Growth and Unlock Value

Compelling opportunity expected to unlock substantial value through enhanced focus, tailored investment and capital allocation, and optimized market valuation

06th February, 2025

BD splits to forge two industry giants driving MedTech and Life Sciences with sharper focus and rapid growth

With a strategic separation, BD is creating a pure-play MedTech leader and a focused Life Sciences and Diagnostics entity, driving enhanced investment, innovation, and market impact.

06th February, 2025

Magic Horizons partners with Senior Care Influencer Lance A. Slatton

The collaboration aims to promote virtual reality solutions for enhancing senior care and well-being.

05th February, 2025

HoneyNaps' AI Sleep Diagnostic Software Earns Dual Innovative Medical Device Designation in South Korea

Simultaneous approval of AI solutions for diagnosing sleep disorders and digital therapeutics for insomnia

04th February, 2025

Onco-Innovations Acquires Inka Health to Boost AI-Driven Cancer Research

Strategic move aims to accelerate advancements in cancer detection and drug development.

04th February, 2025

Gyder Surgical secures FDA 510(k) clearance for GYDER® Hip System

World’s first pin-less, image-less solution for precise acetabular cup positioning in anterior hip arthroplasty.

04th February, 2025

“There remains a high unmet need for new & alternative treatment options for prurigo nodularis & atopic dermatitis”

Asia-Pacific region houses some of Galderma’s fastest growing markets, where sales have fueled a strong performance. There have been multiple successes in the region in 2024 for the Swiss pharmaceutical firm, with a number of important product launches, such as Restylane VOLYME in China, Restylane EYELIGHT in Korea and Alastin in Australia. More recently, Relfydess (RelabotulinumtoxinA) was approved in Australia and Sculptra - which celebrated its 25th launch anniversary this year - was approved in China. Gerry Muhle, Galderma’s Head of Global Product Strategy, spoke to BioSpectrum Asia in detail about the company’s growth plans in 2025 and beyond.

03rd February, 2025

Intelligent Bio Solutions expands global reach with Drug Screening System upgrade

The enhanced system now supports multiple languages, improving accessibility for global drug screening operations.

03rd February, 2025

Memory Lane Games Partners with The Senior Care Influencer Lance A. Slatton as Brand Ambassador

The partnership aims to enhance Memory Lane Games' reach in the senior care community, leveraging Slatton’s influence to promote cognitive health and engagement solutions.

03rd February, 2025

Diag-Nose.io ssecures $2M Seed Funding to Revolutionize Respiratory Care with AI-Powered Precision Medicine

A graduate of CDL-Seattle, Diag-Nose.io aims to enhance respiratory disease diagnosis and treatment through advanced AI-driven solutions.

31st January, 2025

Telix finalizes acquisition of advanced therapeutic assets and cutting-edge biologics technology

The strategic acquisition enhances Telix’s next-generation radiopharmaceutical capabilities, strengthening its position in precision oncology and beyond.

31st January, 2025

Zimmer Biomet to acquire Paragon 28 in Definitive Agreement

The acquisition aims to strengthen Zimmer Biomet’s position in the foot and ankle surgery market with Paragon 28’s specialized solutions.

29th January, 2025

Madhya Pradesh Chief Minister Showcases Ujjain’s Medical Device & Pharma Park to Japanese Investors in Tokyo, Positioning MP Among India’s Leading Industrial States

Dr. Mohan Yadav discusses strategic investment opportunities with A&D Medical, highlighting Madhya Pradesh’s business-friendly policies, infrastructure incentives, and vision for advancing life sciences manufacturing in India.

29th January, 2025